The Research and Development team at Verve Therapeutics is dedicated to pioneering innovative genomic editing therapies aimed at providing lasting protection against coronary artery disease. Comprised of skilled scientists and associates specializing in areas such as bioanalysis, pharmacology, and computational biology, the team collaborates to discover and optimize novel therapeutic approaches while rigorously evaluating their safety and efficacy across preclinical and clinical stages of development.
Amit Khera
Vice President, Genomic Medici...
Athul Sanjeev
Senior Research Associate, RNA...
Christos Miliotis
Scientist, Editor Development
Dhinesh Kannan Srini...
Research Associate, Bioanalysi...
Hareesh Chamarthi
Associate Principal Scientist,...
Paris James
Senior Research Associate, RNA...
Richard Lee
Senior Director, Preclinical P...
Sara Garcia
Associate Principal Scientist,...
Sydney Flannigan
Senior Research Associate, Bio...
Yuri Matsumoto
Associate Director, Bioanalysi...
View all